US20060129228A1 - Stents - Google Patents

Stents Download PDF

Info

Publication number
US20060129228A1
US20060129228A1 US10/527,498 US52749805A US2006129228A1 US 20060129228 A1 US20060129228 A1 US 20060129228A1 US 52749805 A US52749805 A US 52749805A US 2006129228 A1 US2006129228 A1 US 2006129228A1
Authority
US
United States
Prior art keywords
stent
blood vessel
sleeve
stent according
produced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/527,498
Other languages
English (en)
Inventor
Taliesin Golesworthy
Michael Lamperth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exstent Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0221781A external-priority patent/GB0221781D0/en
Application filed by Individual filed Critical Individual
Assigned to EXSTENT LIMITED reassignment EXSTENT LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GOLESWORTHY, TALIESIN JOHN, LAMPERTH, MICHAEL ULRICH
Publication of US20060129228A1 publication Critical patent/US20060129228A1/en
Priority to US12/482,080 priority Critical patent/US8252039B2/en
Priority to US12/533,098 priority patent/US8246673B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2/07—Stent-grafts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00—Products made by additive manufacturing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders

Definitions

  • This invention concerns improvements in or relating to stents for use in humans.
  • the present invention has particular but not exclusive reference to a stent for use in association with the ascending aorta.
  • Aortic dissection is or can be a fatal occurrence since the rupture of the artery occasions dramatic haemorrhaging resulting in system failure.
  • One particular condition afflicting a significant number of people is that known as Marfan's Syndrome which affects the connective tissue in the body to the extent that the aortic root becomes a focus for weakening in time with the pulsing of the blood flow from the heart.
  • the tissue of which the artery is made is weakened and accordingly stretches with a concomitant increase in the diameter of the artery giving rise to dissection or aneurysm.
  • the wall of the artery becomes thinner in section and should distension increase further rupture will occur with the results indicated supra.
  • the aortic valve is formed at the base of the aorta and the distension thereof additionally and adversely affects the operational efficiency of the valve with leakage occurring.
  • aortic root dissection is not confined to sufferers of Marfan's Syndrome and can affect any one.
  • the conventional stents deployed internally are generally produced from synthetic material one example of which is that available under the trade name DACRON®, a polyester with tough elastic properties.
  • synthetic material one example of which is that available under the trade name DACRON®, a polyester with tough elastic properties.
  • internal stent reinforcement giving a degree of rigidity coupled with flexibility is provided and may take the form of a spirally wound open-coiled or mesh insert. The flexibility is necessary to accommodate differing tortuosity of arteries, but the rigidity is also required to resist deformation by kinking for example.
  • An object of the present invention is to provide a new and improved stent that obviates the need for procedures of such an intrusive character as are currently required.
  • a further object of the invention is to provide a method of manufacturing the new and improved stent whereby the resultant stent is of customised form.
  • a stent adapted for location exteriorly of a blood vessel, the stent being formed in such manner as to be locatable around and in morphological relationship with the said blood vessel, and means for maintaining the stent in such relationship with the blood vessel.
  • the stent may include a sleeve that may be in two parts and of generally cylindrical form but may include one or more sections of varying form in order to conform to the morphological requirements in any particular case.
  • the sleeve is provided with appropriately located recesses or apertures for accommodating other interconnecting blood vessels or structures contiguous with the blood vessel being supported by the stent.
  • the sleeve of the stent may be provided with a base or flange portion for attachment to a main heart structure, for example the ventricle muscle, such that a securement or anchor point is established for the stent.
  • the base or flange portion may be adapted for appropriate suturing or other means to the said structure.
  • the other means may include stapling or adhesion.
  • the sleeve may not be required to be secured to the heart structure and may be of such morphological size-matching to the blood vessel as to obviate the need for additional securement. In such event the stent effectively moulds to the shape of the blood vessel, e.g. the ascending aorta, and in this manner provides the necessary support and positive location as required.
  • the stent may be tapered at either end in opposite directions such that when in position on the vessel, the stent locks in position and is thus maintained in its appropriate location.
  • the interconnection of the parts of the sleeve may be effected by a hinge mechanism with releasable latches provided at the mating edges of the parts.
  • the sleeve may be of resilient material slit longitudinally to allow it to be expanded over the wall of the artery and then to recover its original condition, the sleeve being suitably clampable in position embracing the artery in the said morphological relationship.
  • the clamping may be achieved by the application of suitable ties, for example those known as cable ties which lock firmly around the sleeve, which may be provided with one or more grooves for receiving and locating the ties.
  • the clamping may alternatively be effected by the insertion of a locking pin extendable through hinge elements provided at the mating edges of the slit in the sleeve.
  • the sleeve of the stent may be of varying thickness with the greatest thickness being provided in the base or flange region thereof to provide strength at the point of attachment. The thickness may therefore reduce away from that region to afford a degree of flexing given the need to accommodate the pulsing of the blood through the artery.
  • the sleeve may have an outer casing and a relatively inner casing, the outer casing being of more rigid construction than the inner casing which latter may be configured to provide the flexure mentioned above.
  • the inner casing may be of petal-like form to encompass the artery but to allow flexing.
  • the stent of the present invention is formed of one or more parts of spiral formation whereby when in position around the blood vessel close support is given thereto.
  • An advantage of this embodiment lies in its potential for feeding on to the vessel and reforming into a spirally wound coil to provide a unitary support.
  • the spiral formation may form either an open coil or a closed coil and may accordingly constitute a former like structure surrounding the blood vessel.
  • This embodiment may be in one or more sections dependent upon the axial length and form required. Suitable interconnections for the sections are provided and may be in the form of screw fitments or their equivalent whereby upon tightening the coil embraces and supports the blood vessel.
  • the spiral form of stent of the present invention may allow tissue growth within its interstices thereby serving to enhance its integrity in relation to the blood vessel and concomitantly its strength.
  • the inner surface of the stent must be of a smoothness to ensure that no fretting or abrasion occurs and for similar reasons the external surface of the stent must equally be tolerant of other adjacent body parts, for example other blood vessels or the pericardial wall.
  • the inner surface of the stent may be suitably contoured or profiled to minimise fretting or abrasion and to assist in the egress of metabolites that may issue from the outer surface of the blood vessel into contact with the stent.
  • the inner surface of the stent may in this even assist in the movement of the metabolites into the pericardial space possibly with a peristaltic effect.
  • the contouring or customising of the stent in this fashion assists in restricting axial movement of the blood vessel, e.g. the aorta, tending thereby to ensure the containment of the vessel within the limits of the stent.
  • the stent thus acts as a mechanical barrier to axial as well as diametral movement of the blood vessel.
  • the material from which the stent is produced must possess structural integrity in terms of its burst strength, bend strength, tensile strength, liquid porosity, load distribution and general security particularly for mounting to the heart muscle. Further the material should possess a degree of opacity but should be translucent for the purposes of allowing non-intrusive investigative procedures to take place, for example MRI scanning. The material should, however, be resistant to the effect of electromagnetic fields.
  • the material must also be thermally stable given the potentially variable nature of its working environment and has to be biocompatible in terms of its location within the body structure. In particular, it must possess mechanical, chemical, thermal, proteinal, enzymal and pericardial fluid biocompatibility and resistance to attack from any of these sources.
  • the material from which the stent may be made may contain antibiotics gradually releasable in time, the antibiotic elements being incorporated during the manufacture of the stent.
  • the material from which the stent may be made may be polymeric, metallic, or ceramic or appropriate mixtures thereof to meet the requirements of strength and compatibility hereinbefore mentioned.
  • Another material that may be appropriate is a heat shrink plastics material that would be recoverable in terms of shape either immediately or over a period of time to produce the morphological fit, which is an important novel and inventive step of the present invention.
  • the recovery of the plastics material may be in-built such that it occurs over a period of time or in the alternative the recovery could be triggered by appropriate external means.
  • the material from which the stent may be produced may be polymeric polypropylene, polyester, PTFE or a polyoxymethylene homopolymer such as that available from Du Pont under the name DELRIN®, or a ultra high molecular weight polyethylene. Further, the polymeric material may have applied thereto embroidery of suitable material, for example suture material.
  • the stent of the invention may be of such form as to be adjustable following its initial application to the affected blood vessel. Such adjustment may be capable of initiation externally of the patient's body and may be electronic.
  • a method of manufacturing a stent according to the first aspect for morphologically fitting an artery including the steps of producing a computerised 3D model from a scanned image of the artery to which the stent is in practice to be applied, and rapid prototyping the computerised 3D model in an appropriate material to provide the stent or a mould for the stent or a precursor therefor.
  • the material from which the stent may be made may be polymeric and there may be applied thereto a woven or embroidered structure made of for example suture thread.
  • One method of making the morphological form of stent according to the second aspect of the invention is to generate a thin polymeric shell of appropriate form and then to lay down thereon a meshwork of filamentary material to produce a embroidered or textile layer of its own inherent integrity on the surface of the polymeric shell which acts as a former for the stent.
  • the polymeric material is removed by suitable means, for example by thermal, chemical or solvent means thus leaving the morphologically shaped stent constituted by the woven structure.
  • suitable means for example by thermal, chemical or solvent means
  • a thin 3-dimensional shell is produced from polymeric material conforming to the morphological profile of the vessel for which the stent is intended.
  • the stent is generated by heat forming, machining, rapid prototyping or similar process and is then mounted in a computer numerically controlled machine having multi-axis control. Appropriate perforations in the shell are then machined in to provide the requisite apertures and other features with the apposite mechanical properties.
  • the machining may be accomplished using one or more of a variety of processes, viz. water jet cutting, laser cutting, drilling or other appropriate machining methods.
  • a still further method involves the use of a flaccid support which mimics the three-dimensional morphology of the desired form and the application thereto of an embroidered or woven structure using a computer numerically controlled machine incorporating variable support radius.
  • a flaccid support which mimics the three-dimensional morphology of the desired form and the application thereto of an embroidered or woven structure using a computer numerically controlled machine incorporating variable support radius.
  • a further method of producing the stent includes the steps of opening the thorax of the patient, the applying a polymeric wrap by hand to an approximate fit around the blood vessel and thermally treating the wrap to fix it in situ to the shape of the vessel, and closing the thorax.
  • a still further method of producing the stent includes the steps of opening the thorax and the pericardium, applying shuttering to the blood vessel, injecting room temperature vulcanising (RTV) or room temperature curing polymer around the blood vessel and within the shuttering, allowing the setting of the polymer, removing the shuttering and closing the thorax.
  • RTV room temperature vulcanising
  • a third aspect of the invention is a stent made in accordance with the method.
  • the scanned image may be generated for example from an MRI procedure applied to the affected artery of the patient and is then computerised and converted into a stent design.
  • Other investigative procedures may be adopted for the initial imaging step, for example MRA, X-ray CT, 3D pulsed Doppler Echo measuring, namely a 3D version of 2D echocardiography used for aortic root measurement, and any other appropriate imaging technique.
  • Suitable CAD software is employed to create the requisite customised 3D model of the affected artery and this image is then utilised for the rapid prototyping stage.
  • the rapid prototyping conventionally known in its abbreviated form as ‘RP’, is conducted on a suitable machine in which is produced in a suitable material a three-dimensional reproduction of the CAD image.
  • the RP reproduction may give the actual stent or may provide the model from which the stent may be produced.
  • the model may be used to generate a mould from which the stent may be produced, in a similar vein to the ‘lost wax’ process.
  • the stent so generated is customised for the individual patient and contrasts sharply with the current procedures using internally applied stents of stock sizes.
  • the RP method may employ Stereo Lithography (SLA), Selective Laser Sintering (SLS) Solid ground curing (SOLIDER) Laminated object manufacturing (LOM) Fused deposition modelling (FDM) or Computer Numerical Controlled (CNC) machining for producing the stent.
  • SLA Stereo Lithography
  • SOLIDER Selective Laser Sintering
  • LOM Laminated object manufacturing
  • FDM Fused deposition modelling
  • CNC Computer Numerical Controlled
  • FIG. 1 shows a typical horizontal section through a human thorax clearly indicating the structures of the heart.
  • FIG. 2 shows a digitally highlighted horizontal section of the ascending aorta taken from a thoracic MRI image
  • FIG. 3 shows a CAD reconstruction of an ascending aorta and aortic arch.
  • FIG. 4 shows a CAD reconstruction of an ascending aorta and aortic arch post smoothing
  • FIG. 5 shows a superimposition of a CAD reconstruction of an ascending aorta with one of the source MRI data files superimposed in the correct spatial position.
  • FIG. 6 shows an external support in 2 pieces.
  • the patient is first scanned using a standard medical MRI unit.
  • the scans are taken of the affected structure, e.g. ascending aorta, in such a way as to provide adjacent images substantially axial to the plane of the aorta.
  • Poor quality images may be enhanced by multiple imaging and averaging/superposition of identical images.
  • FIG. 1 below shows a typical horizontal section through a human thorax clearly indicating the structures of the heart.
  • Reference numeral 1 indicates the spine at the rear of the thorax
  • 2 indicates the left lung and 3 the structures of the heart.
  • FIG. 2 shows a similar MRI horizontal section through a human thorax including the spine 1 , the left lung 2 , the heart 3 and a section of the ascending aorta digitally highlighted at 4 .
  • FIG. 3 shows a CAD reconstruction including the ascending aorta 4 , the aortic root containing the aortic valve 5 , the aortic arch 6 and the coronary artery origins 7 .
  • FIG. 4 shows a CAD model of the same ascending aorta 4 , aortic root 5 , aortic 6 and coronary origins 7 , post smoothing
  • the CAD model can be validated within some CAD packages by superimposition of base MRI image data onto the finished CAD model.
  • FIG. 5 below shows the superimposition of the CAD reconstruction with an MRI image slice from the source data. Structures visible include the upper part of the ascending aorta 4 and the aortic arch 6
  • the CAD model can then be used to manufacture a tool from which the stent can be manufactured.
  • the physical model can be manufactured as follows:
  • the CAD model file can be transferred to an appropriate Rapid Prototyping machine, eg a stereo lithography machine (SLA) to produce a physical model of the ascending aorta in a polymer, e.g. UV curable epoxy resin.
  • SLA stereo lithography machine
  • This model can then be used to produce a mould in a silicone rubber.
  • the mould can then be used to produce daughter models of the aorta.
  • Other manufacturing techniques can be used, for example selective laser sintering (SLS), CNC machining etc.
  • surgical implantation is effected by conventional means using existing surgical procedures to reveal the ascending aorta from the aortic annulus to the arch and accommodating the coronary arteries.
  • Said means would include for example surgical sub-procedures taken from the Ross procedure to expose the aortic annulus.
  • the stent of the invention conforms morphologically to the contours of the affected artery and when applied effectively provides a clamped sleeve to support its exterior in substantially full contact therewith.
  • the clamping of the sleeve also provides an adjustment for the aortic valve in terms of repositioning the valve seat to reinstate or reinforce integrity to prevent leakage at this location, thus avoiding the need to replace the valve.
  • the present invention does not require the high degree of invasive surgery associated with conventional surgical procedures for aortic root resection and valve replacement.
  • the stent is in place although clearly it is in contact with bodily fluids and internal features of the pericardium and neighbouring parts, its external nature means that it is not in contact with blood.
  • This very facet of the invention is of high benefit in terms of avoiding the possibility of infection affecting the blood stream and also obviates or significantly reduces the dependency of the patient, having undergone the successful procedure, on aftercare and drugs and treatment associated therewith. Quite apart from these advantages the avoidance of such invasive surgery is clearly less traumatic for the patient.
  • Beating heart surgery thus becomes a possibility by virtue of the present invention, which provides a bespoke stent. Indeed with some forms of the stent, for example the spirally wound version, the opportunity arises for keyhole surgery with all the attendant advantages which that offers in terms of non-intrusive procedures with less patient trauma and post-operative care and medication.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Prostheses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
US10/527,498 2002-09-19 2003-09-18 Stents Abandoned US20060129228A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12/482,080 US8252039B2 (en) 2002-09-19 2009-06-10 Aortic root dissection treatment
US12/533,098 US8246673B2 (en) 2002-09-19 2009-07-31 External support for a blood vessel

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0221781.8 2002-09-19
GB0221781A GB0221781D0 (en) 2002-09-19 2002-09-19 Improvements in or relating to stents
GB0308517A GB0308517D0 (en) 2002-09-19 2003-04-14 Improvements in or relating to stents
GB0308517.2 2003-04-14
PCT/GB2003/004135 WO2004026178A2 (en) 2002-09-19 2003-09-18 External stent

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/482,080 Division US8252039B2 (en) 2002-09-19 2009-06-10 Aortic root dissection treatment
US12/533,098 Continuation-In-Part US8246673B2 (en) 2002-09-19 2009-07-31 External support for a blood vessel

Publications (1)

Publication Number Publication Date
US20060129228A1 true US20060129228A1 (en) 2006-06-15

Family

ID=32031883

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/527,498 Abandoned US20060129228A1 (en) 2002-09-19 2003-09-18 Stents
US12/482,080 Expired - Lifetime US8252039B2 (en) 2002-09-19 2009-06-10 Aortic root dissection treatment

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/482,080 Expired - Lifetime US8252039B2 (en) 2002-09-19 2009-06-10 Aortic root dissection treatment

Country Status (7)

Country Link
US (2) US20060129228A1 (enExample)
EP (1) EP1539035B1 (enExample)
JP (1) JP4280710B2 (enExample)
AU (1) AU2003269187A1 (enExample)
CA (1) CA2497966C (enExample)
PL (1) PL375863A1 (enExample)
WO (1) WO2004026178A2 (enExample)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070168066A1 (en) * 2006-01-18 2007-07-19 Randy-David Burce Grishaber AAA model for fatigue testing
US20070294151A1 (en) * 2006-06-16 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Specialty stents with flow control features or the like
US20070294210A1 (en) * 2006-06-16 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Stent customization system and method
US20080058633A1 (en) * 2006-06-16 2008-03-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for specifying a blood vessel sleeve
US20080077265A1 (en) * 2006-06-16 2008-03-27 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for making a blood vessel sleeve
US20080082160A1 (en) * 2006-06-16 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Rapid-prototyped custom-fitted blood vessel sleeve
US20080133040A1 (en) * 2006-06-16 2008-06-05 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for specifying a blood vessel sleeve
US20080172073A1 (en) * 2006-06-16 2008-07-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Active blood vessel sleeve
US20080201007A1 (en) * 2006-06-16 2008-08-21 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for making a blood vessel sleeve
US20080262341A1 (en) * 2006-06-16 2008-10-23 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Active blood vessel sleeve methods and systems
US20080286735A1 (en) * 2005-07-20 2008-11-20 Dies Srl System and a Method for Simulating a Manual Interventional Operation by a User in a Medical Procedure
US20090024152A1 (en) * 2007-07-17 2009-01-22 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Custom-fitted blood vessel sleeve
US20090248138A1 (en) * 2002-09-19 2009-10-01 Golesworthy Taliesin John Stents
US20090292349A1 (en) * 2002-09-19 2009-11-26 Golesworthy Taliesin John Supports
US20100268320A1 (en) * 2009-04-17 2010-10-21 Medtronic Vascular, Inc. Endovascular Implant Having an Integral Graft Component and Method of Manufacture
US20130018665A1 (en) * 2011-07-13 2013-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Specialty stents with flow control features or the like
US20140222184A1 (en) * 2011-10-07 2014-08-07 Materialise N.V. Methods for the manufacture of intraluminal endoprosthesis
US9533078B2 (en) 2008-06-25 2017-01-03 Boston Scientific Scimed, Inc. Medical devices containing therapeutic agents
US10897678B2 (en) * 2008-10-15 2021-01-19 Staton Techiya, Llc Device and method to reduce ear wax clogging of acoustic ports, hearing aid sealing system, and feedback reduction system
US11389171B2 (en) * 2006-11-21 2022-07-19 David S. Goldsmith Integrated system for the infixion and retrieval of implants
CN118453215A (zh) * 2024-06-12 2024-08-09 北京大学人民医院 一种升主动脉外支架

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9642726B2 (en) 2005-07-25 2017-05-09 Vascular Dynamics, Inc. Devices and methods for control of blood pressure
US9125732B2 (en) 2005-07-25 2015-09-08 Vascular Dynamics, Inc. Devices and methods for control of blood pressure
US9592136B2 (en) 2005-07-25 2017-03-14 Vascular Dynamics, Inc. Devices and methods for control of blood pressure
US8923972B2 (en) 2005-07-25 2014-12-30 Vascular Dynamics, Inc. Elliptical element for blood pressure reduction
WO2007131552A1 (en) * 2006-05-17 2007-11-22 Syntach Ag A patient configured device, a kit and a method for treatment of disorders in the heart rhythm regulation system
DE102007061301A1 (de) 2007-12-10 2009-06-18 Aesculap Ag Ummantelung zur Wiederherstellung der Klappenfunktion variköser Venen und Verwendung der Ummantelung in der Chirurgie
EP2346405B1 (en) 2008-09-26 2019-03-13 Vascular Dynamics Inc. Devices and methods for control of blood pressure
DK2361059T3 (da) 2008-11-24 2014-08-18 Vascular Graft Solutions Ltd Ekstern stent
EP2589476A4 (en) * 2010-07-01 2014-08-06 Crosseffect Inc METHOD FOR PRODUCING A RESIN MOLDED BODY OF A HOLLOW STRUCTURE BODY, AND CORE
WO2012143925A1 (en) 2011-04-18 2012-10-26 Vascular Graft Solutions Ltd Devices and methods for deploying implantable sleeves over blood vessels
EP2903561B1 (en) 2012-10-05 2020-03-18 Materialise N.V. Method of making a customized aortic stent device
GB201402643D0 (en) 2014-02-14 2014-04-02 Univ Southampton A method of mapping images of human disease
PL3941392T3 (pl) 2019-03-20 2025-08-25 inQB8 Medical Technologies, LLC Implant do leczenia rozwarstwienia aorty
JP2022540245A (ja) * 2019-07-11 2022-09-14 ザ クリーヴランド クリニック ファウンデーション モデルに基づくステントの設計及び配置のためのシステム及び方法
DE102019131618B4 (de) 2019-11-22 2022-03-17 Novatech Sa Verfahren zur Herstellung eines Implantats aus einem biokompatiblen Silikon
GB2602045B (en) * 2020-12-16 2025-02-12 Exstent Ltd Model and method of modelling a pulmonary autograft

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626947A (en) * 1970-02-19 1971-12-14 Charles Howard Sparks Method and apparatus for vein and artery reenforcement
US4904254A (en) * 1986-07-17 1990-02-27 Vaso Products Australia Pty. Limited Correction of incompetent venous valves
US5245456A (en) * 1990-10-24 1993-09-14 Nitto Denko Corporation Birefringent film with nx >nz >ny, process for producing the same, retardation film, elliptically polarizing plate, and liquid crystal display
US5476471A (en) * 1993-08-19 1995-12-19 Mind - E.M.S.G. Ltd Device and method for external correction of insufficient valves in venous junctions
US5573776A (en) * 1992-12-02 1996-11-12 Alza Corporation Oral osmotic device with hydrogel driving member
US5741215A (en) * 1993-09-10 1998-04-21 The University Of Queensland Stereolithographic anatomical modelling process
US6160084A (en) * 1998-02-23 2000-12-12 Massachusetts Institute Of Technology Biodegradable shape memory polymers
US6165193A (en) * 1998-07-06 2000-12-26 Microvention, Inc. Vascular embolization with an expansible implant
US6197050B1 (en) * 1998-09-14 2001-03-06 Heartstent Corporation Transmyocardial implant with compliance collar
US20020068968A1 (en) * 2000-08-16 2002-06-06 Thomas Hupp Virtual stent making process based upon novel enhanced plate tectonics derived from endoluminal mapping
US20020103527A1 (en) * 2001-01-30 2002-08-01 Kocur Gordon John Stent with channel(s) for containing and delivering a biologically active material and method for manufacturing the same
US6554856B1 (en) * 1997-05-27 2003-04-29 Imperial College Of Science, Technology & Medicine Stents for blood vessels
US6648911B1 (en) * 2000-11-20 2003-11-18 Avantec Vascular Corporation Method and device for the treatment of vulnerable tissue site
US6899728B1 (en) * 1998-01-26 2005-05-31 Bridport (Uk) Limited Reinforced graft
US20060036311A1 (en) * 2002-08-23 2006-02-16 Yasuhide Nakayama Stent and process for producing the same
US7073456B2 (en) * 2001-05-01 2006-07-11 Anson Medical Limited Method for manufacturing stent-grafts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2090143A (en) 1980-12-31 1982-07-07 Archibald Steven Lee Micro-arterial sleeve-grip
US5246456A (en) * 1992-06-08 1993-09-21 Wilkinson Lawrence H Fenestrated gastric pouch
US5246546A (en) * 1992-08-27 1993-09-21 Procter & Gamble Company Process for applying a thin film containing polysiloxane to tissue paper
JP2000510006A (ja) * 1996-04-29 2000-08-08 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 静脈弁の能力回復装置
GB2344053A (en) 1998-11-30 2000-05-31 Imperial College Stents for blood vessels
DK1055401T3 (da) 1999-05-26 2004-02-16 Nec Tokin Corp Indretning til anastomose af blodkar
US6436132B1 (en) * 2000-03-30 2002-08-20 Advanced Cardiovascular Systems, Inc. Composite intraluminal prostheses
JP2002035135A (ja) 2000-07-31 2002-02-05 Manii Kk ステント及びステントの製造方法
CA2497966C (en) 2002-09-19 2011-07-26 Exstent Limited Improvements in or relating to stents

Patent Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626947A (en) * 1970-02-19 1971-12-14 Charles Howard Sparks Method and apparatus for vein and artery reenforcement
US4904254A (en) * 1986-07-17 1990-02-27 Vaso Products Australia Pty. Limited Correction of incompetent venous valves
US5245456A (en) * 1990-10-24 1993-09-14 Nitto Denko Corporation Birefringent film with nx >nz >ny, process for producing the same, retardation film, elliptically polarizing plate, and liquid crystal display
US5573776A (en) * 1992-12-02 1996-11-12 Alza Corporation Oral osmotic device with hydrogel driving member
US5476471A (en) * 1993-08-19 1995-12-19 Mind - E.M.S.G. Ltd Device and method for external correction of insufficient valves in venous junctions
US5741215A (en) * 1993-09-10 1998-04-21 The University Of Queensland Stereolithographic anatomical modelling process
US6112109A (en) * 1993-09-10 2000-08-29 The University Of Queensland Constructive modelling of articles
US6554856B1 (en) * 1997-05-27 2003-04-29 Imperial College Of Science, Technology & Medicine Stents for blood vessels
US6899728B1 (en) * 1998-01-26 2005-05-31 Bridport (Uk) Limited Reinforced graft
US6160084A (en) * 1998-02-23 2000-12-12 Massachusetts Institute Of Technology Biodegradable shape memory polymers
US6165193A (en) * 1998-07-06 2000-12-26 Microvention, Inc. Vascular embolization with an expansible implant
US6197050B1 (en) * 1998-09-14 2001-03-06 Heartstent Corporation Transmyocardial implant with compliance collar
US20020068968A1 (en) * 2000-08-16 2002-06-06 Thomas Hupp Virtual stent making process based upon novel enhanced plate tectonics derived from endoluminal mapping
US6648911B1 (en) * 2000-11-20 2003-11-18 Avantec Vascular Corporation Method and device for the treatment of vulnerable tissue site
US20020103527A1 (en) * 2001-01-30 2002-08-01 Kocur Gordon John Stent with channel(s) for containing and delivering a biologically active material and method for manufacturing the same
US7073456B2 (en) * 2001-05-01 2006-07-11 Anson Medical Limited Method for manufacturing stent-grafts
US7290494B2 (en) * 2001-05-01 2007-11-06 Anson Medical Limited Method for manufacturing stent-grafts
US20060036311A1 (en) * 2002-08-23 2006-02-16 Yasuhide Nakayama Stent and process for producing the same

Cited By (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252039B2 (en) 2002-09-19 2012-08-28 Golesworthy Taliesin John Aortic root dissection treatment
US8246673B2 (en) 2002-09-19 2012-08-21 Exstent Limited External support for a blood vessel
US20090292349A1 (en) * 2002-09-19 2009-11-26 Golesworthy Taliesin John Supports
US20090248138A1 (en) * 2002-09-19 2009-10-01 Golesworthy Taliesin John Stents
US20080286735A1 (en) * 2005-07-20 2008-11-20 Dies Srl System and a Method for Simulating a Manual Interventional Operation by a User in a Medical Procedure
US8485829B2 (en) * 2005-07-20 2013-07-16 DIES S.r.l. System and a method for simulating a manual interventional operation by a user in a medical procedure
US20070168066A1 (en) * 2006-01-18 2007-07-19 Randy-David Burce Grishaber AAA model for fatigue testing
US7818084B2 (en) 2006-06-16 2010-10-19 The Invention Science Fund, I, LLC Methods and systems for making a blood vessel sleeve
US20120089414A1 (en) * 2006-06-16 2012-04-12 Searete Llc Specialty Stents with flow control features or the like
US20070293966A1 (en) * 2006-06-16 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Specialty stents with flow control features or the like
US20080058633A1 (en) * 2006-06-16 2008-03-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for specifying a blood vessel sleeve
US20080077265A1 (en) * 2006-06-16 2008-03-27 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for making a blood vessel sleeve
US20080082160A1 (en) * 2006-06-16 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Rapid-prototyped custom-fitted blood vessel sleeve
US20080133040A1 (en) * 2006-06-16 2008-06-05 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for specifying a blood vessel sleeve
US20080172073A1 (en) * 2006-06-16 2008-07-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Active blood vessel sleeve
US20080201007A1 (en) * 2006-06-16 2008-08-21 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for making a blood vessel sleeve
US20080262341A1 (en) * 2006-06-16 2008-10-23 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Active blood vessel sleeve methods and systems
US20070294280A1 (en) * 2006-06-16 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Stent customization system and method
WO2007149430A3 (en) * 2006-06-16 2008-11-27 Searete Llc Specialty stents with flow control features or the like
US8721706B2 (en) * 2006-06-16 2014-05-13 The Invention Science Fund I, Llc Specialty stents with flow control features or the like
US20090084844A1 (en) * 2006-06-16 2009-04-02 Jung Edward K Y Specialty stents with flow control features or the like
US20070294152A1 (en) * 2006-06-16 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Specialty stents with flow control features or the like
US20070293963A1 (en) * 2006-06-16 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Stent customization system and method
US7769603B2 (en) * 2006-06-16 2010-08-03 The Invention Science Fund I, Llc Stent customization system and method
US20070294150A1 (en) * 2006-06-16 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Specialty stents with flow control features or the like
US8551155B2 (en) * 2006-06-16 2013-10-08 The Invention Science Fund I, Llc Stent customization system and method
US8095382B2 (en) 2006-06-16 2012-01-10 The Invention Science Fund I, Llc Methods and systems for specifying a blood vessel sleeve
US8147537B2 (en) 2006-06-16 2012-04-03 The Invention Science Fund I, Llc Rapid-prototyped custom-fitted blood vessel sleeve
US20070293965A1 (en) * 2006-06-16 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Stent customization system and method
US8163003B2 (en) 2006-06-16 2012-04-24 The Invention Science Fund I, Llc Active blood vessel sleeve methods and systems
US20070294279A1 (en) * 2006-06-16 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Stent customization system and method
US20070294210A1 (en) * 2006-06-16 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Stent customization system and method
US8550344B2 (en) 2006-06-16 2013-10-08 The Invention Science Fund I, Llc Specialty stents with flow control features or the like
US8430922B2 (en) 2006-06-16 2013-04-30 The Invention Science Fund I, Llc Stent customization system and method
US8478437B2 (en) 2006-06-16 2013-07-02 The Invention Science Fund I, Llc Methods and systems for making a blood vessel sleeve
US8475517B2 (en) * 2006-06-16 2013-07-02 The Invention Science Fund I, Llc Stent customization system and method
US20070294151A1 (en) * 2006-06-16 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Specialty stents with flow control features or the like
US11389171B2 (en) * 2006-11-21 2022-07-19 David S. Goldsmith Integrated system for the infixion and retrieval of implants
US20090024152A1 (en) * 2007-07-17 2009-01-22 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Custom-fitted blood vessel sleeve
US9533078B2 (en) 2008-06-25 2017-01-03 Boston Scientific Scimed, Inc. Medical devices containing therapeutic agents
US10897678B2 (en) * 2008-10-15 2021-01-19 Staton Techiya, Llc Device and method to reduce ear wax clogging of acoustic ports, hearing aid sealing system, and feedback reduction system
US10979831B2 (en) 2008-10-15 2021-04-13 Staton Techiya, Llc Device and method to reduce ear wax clogging of acoustic ports, hearing aid sealing system, and feedback reduction system
US8480727B2 (en) 2009-04-17 2013-07-09 Medtronic Vascular, Inc. Endovascular implant having an integral graft component and method of manufacture
US20100268320A1 (en) * 2009-04-17 2010-10-21 Medtronic Vascular, Inc. Endovascular Implant Having an Integral Graft Component and Method of Manufacture
US20130018665A1 (en) * 2011-07-13 2013-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Specialty stents with flow control features or the like
US8577693B2 (en) * 2011-07-13 2013-11-05 The Invention Science Fund I, Llc Specialty stents with flow control features or the like
US20140222184A1 (en) * 2011-10-07 2014-08-07 Materialise N.V. Methods for the manufacture of intraluminal endoprosthesis
US9772621B2 (en) * 2011-10-07 2017-09-26 Materialise N.V. Methods for the manufacture of intraluminal endoprosthesis
CN118453215A (zh) * 2024-06-12 2024-08-09 北京大学人民医院 一种升主动脉外支架

Also Published As

Publication number Publication date
AU2003269187A1 (en) 2004-04-08
EP1539035A2 (en) 2005-06-15
EP1539035B1 (en) 2011-08-17
JP4280710B2 (ja) 2009-06-17
JP2006500093A (ja) 2006-01-05
CA2497966C (en) 2011-07-26
US8252039B2 (en) 2012-08-28
AU2003269187A8 (en) 2004-04-08
WO2004026178A2 (en) 2004-04-01
CA2497966A1 (en) 2004-04-01
US20090248138A1 (en) 2009-10-01
PL375863A1 (en) 2005-12-12
WO2004026178A3 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
US8252039B2 (en) Aortic root dissection treatment
US8246673B2 (en) External support for a blood vessel
JP2006500093A5 (enExample)
US20250332794A1 (en) Fenestration template for endovascular repair of aortic aneurysms
US5360014A (en) Sizing apparatus for heart valve with supra annular suture ring
US11096726B2 (en) Composite internal fixators
US5741215A (en) Stereolithographic anatomical modelling process
ES2459953T3 (es) Guías para pasadores ortopédicos específicas de un paciente personalizadas
JP6979010B2 (ja) 補綴インプラントのための解剖学的マッピングのための装置および方法
WO2014090908A1 (en) Surgical guiding tools for orthopedic surgery and systems and methods of manufacturing the same
Berry et al. Flexible tubular replicas of abdominal aortic aneurysms
US11992400B2 (en) Stent graft and method for producing same
EP4231945A1 (en) Bone fixation system for human bone, method of designing and manufacturing thereof
ES2369533T3 (es) Mejoras relativas a stents.
BR112021013141A2 (pt) Processo de fabricação automatizada de endoprótese vascular
Brennan Production of anatomical models from CT scan data
Jeyaraj et al. Cutting Edge Era of Additively Manufactured Patient Specific Titanium Implants for Expeditious Extensive Cranioplasties
AU2021404147A1 (en) Model and method of modelling a pulmonary autograft

Legal Events

Date Code Title Description
AS Assignment

Owner name: EXSTENT LIMITED, UNITED KINGDOM

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GOLESWORTHY, TALIESIN JOHN;LAMPERTH, MICHAEL ULRICH;REEL/FRAME:016853/0049

Effective date: 20050511

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION